What is Digipath, Inc. (DIGP)?

Digipath, Inc. (DIGP) is a stock in the Healthcare sector, Medical - Diagnostics & Research industry. View full analysis on Stocks360.

What is the current price of DIGP?

The current price of DIGP is $0.01. Prices are updated in real time on Stocks360.

What is DIGP's price-to-earnings (PE) ratio?

DIGP's trailing twelve-month PE ratio is -1.21, based on current price and earnings per share data available on Stocks360.

What is DIGP's market capitalization?

DIGP's market capitalization is $1,094,912.00, placing it in the small-cap tier.

Digipath, Inc. (DIGP)

Stock analysis · OTC · Healthcare · Medical - Diagnostics & Research

$0.01

Market Cap

$1.09M

PE (TTM)

-1.21

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

0.42

Day Range

$0.01 – $0.01

52-wk Range

$0.01 – $0.07

Avg Volume

N/A

Volume

12.00K

Digipath, Inc. (DIGP) is a publicly traded company in the Healthcare sector. Latest price: $0.01. Market cap $1.09M. Trailing PE -1.21. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

You have viewed 6 SEO analysis pages

Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.

Continue with free signup

Proprietary Signals

Signal snapshot temporarily unavailable.

About Digipath, Inc.

Digipath, Inc., with its subsidiaries, offers essential laboratory testing for cannabis and hemp, primarily serving Nevada's licensed medical marijuana enterprises from its base in Las Vegas. Beyond these core analytical services, the company also provides comprehensive support to the broader cannabis industry, including educational programs, professional training, and news coverage. As a dedicated testing laboratory, Digipath analyzes various products such as cannabis, cannabis-infused items, hemp, and other botanical nutraceuticals, catering to cultivators, dispensaries, caregivers, producers, patients, and end-users of these botanical goods. A critical aspect of their operations involves rigorously screening medicinal and recreational cannabis for potential contaminants. This includes checks for residual solvents, moisture content, water activity, and visual integrity, alongside identifying pesticides, a spectrum of heavy metals (like mercury, arsenic, lead, cadmium, chromium, and nickel), biological toxins (including aflatoxin and ocratoxins), and a wide array of microbial contaminants (such as E. coli, salmonella, coliforms, aspergillus, gram-negative bacteria, total aerobic…

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-1.21×
P/S (TTM)	0.00×
P/B	-0.55×
P/FCF (TTM)	-1.83×
EV / EBITDA	4.75×
EV / Sales	0.00×
Earnings Yield	-111.82%
Free Cash Flow Yield	-54.73%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$2.88M
Net Income (TTM)	-$1.22M
Free Cash Flow (TTM)	-$1.03M
Net Debt	$1.79M
Working Capital	-$1.58M
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Return on Equity	73.84%
Return on Invested Capital	43.18%